InsideArbitrage November 2024 Mid-Month Update – Revisiting Postal Realty Trust
I was torn between writing about Capri (CPRI) considering it called off its merger with Tapestry (TPR) yesterday and providing an update about Postal Realty
Read MoreI was torn between writing about Capri (CPRI) considering it called off its merger with Tapestry (TPR) yesterday and providing an update about Postal Realty
Read MoreFor this mid-month update I want to focus on a SPAC that for the better part of two years after completing its business combination with
Read MoreFor this mid-month update, I am going to focus on two energy related opportunities. One is a short-term odd lot tender opportunity and the second
Read MoreThe Mean Reversion Volatility Trade The extreme volatility we saw at the beginning of last week thanks to the impact of a small increase in
Read MoreLululemon Athletica (LULU): $283.72 Market Cap: $36.38B Enterprise Value: $35.88B Our pick for the June 2024 mid-month update Zillow (ZG) following an insider purchase by board
Read MoreZillow – Class A (ZG): $46.55 Market Cap: $11.37B Enterprise Value: $10.30B Key Insights: Independent Director Jay Hoag, who has served on Zillow’s board since 2005
Read MoreHoward Hughes, Inc. (HHH): $68.13 Market Cap: $3.40B Sum-of-the-Parts Estimate Per Share: $129 (as of June 30, 2023) Howard Hughes is probably one of most misunderstood
Read MoreInvestor sentiment is often as fickle as fad diets, turning on a whim. We observed that happen when our preferred sentiment indicator, the CNN Fear
Read MoreColumbia Banking System Inc. (COLB): $18.46 Tangible Book Value Per Share: $16.12 (as of December 31, 2023) Market Cap: $4.02 B Last month I noticed a cluster
Read MoreEarlier this week our portfolio company Diamondback Energy (FANG), announced an oil megadeal by acquiring its fellow Permian Basin fracking company Endeavor Energy Resources LP
Read MoreCerevel Therapeutics (CERE): $42.64 We are publishing this mid-month update a few days early because the HSR waiting period for AbbVie’s acquisition of Cerevel Therapeutics (CERE)
Read MoreThe market is a forward looking mechanism that correctly anticipated that two subsequent pauses by the Fed will translate into the potential for rate cuts
Read More